Counselors in Dixon, CA Accepting Medicare

7 Counselors found. Showing 1 - 7

Douglas Carr, CADC-I Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 255 N Lincoln St, Dixon, CA 95620 Phone: 707-693-1733    Fax: 707-693-1705

Kelly Lee Montoya, MFT Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1550 Valley Glen Dr Apt 225, Dixon, CA 95620 Phone: 805-709-6127

Liliana Diaz-rodriguez Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 2025 Regency Pkwy, Dixon, CA 95620 Phone: 707-410-6232

Mrs. Margie Louise Hackett, M.C. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 125 N Lincoln St, Suite H, Dixon, CA 95620 Phone: 707-678-7689    Fax: 707-678-0666

Solji Kim Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1085 Purdue Ct, Dixon, CA 95620 Phone: 302-893-9409

Robin Jackson, RW Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 255 N Lincoln St, Dixon, CA 95620 Phone: 707-693-1733    Fax: 707-693-1705

Angel Ann-marie Gatchel Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 715 Berkshire Ct, Dixon, CA 95620 Phone: 707-365-3104

News Archive

China SFDA approves Veridex's CellSearch test for women with metastatic breast cancer

Veridex, LLC today announced approval from the China State Food & Drug Administration (SFDA) for the CellSearch circulating tumor cell (CTC) test as an in vitro diagnostic for women with metastatic breast cancer.

ReBuilder Medical Technologies reports 100% increase in second-quarter 2009 profits over first-quarter

ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it has published its second quarter 09 profits and that profits are up 100% over the first quarter.

FDA approves HUD designation for SynCardia temporary Total Artificial Heart for destination therapy

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the U.S. Food and Drug Administration has approved a Humanitarian Use Device (HUD) designation for the SynCardia temporary Total Artificial Heart to be used for destination therapy in addition to its current PMA approval as a bridge to transplant.

Boys more vulnerable and emotionally engaged in romantic relationships than previously thought

Teenage boys have feelings, too, and when it comes to matters of the heart, they may not be so fleeting after all. Not far beneath the bravado often on display is an unsure adolescent who finds it hard to express emotions that, while new, are nonetheless often sincerely felt.

Patent infringement suit filed against Impax Laboratories in connection with Detrol

Impax Laboratories, Inc. today confirms that Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB have filed suit for patent infringement against Impax in the United States District Court for the District of New Jersey in connection with Detrol (tolterodine tartrate) immediate-release, 1 mg and 2 mg tablets.

Read more Medical News

› Verified 4 days ago